Alzheimer's Network for Treatment and Diagnostics (ALZ-NET)

The Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) is a voluntary provider-enrolled network that collects real-world data from people evaluated for or treated with new FDA-approved Alzheimer’s therapies. It serves as a resource for gathering evidence, sharing information and improving patient quality of care.

ALZ-NET offers resources and education for clinicians and health care providers. Patients, families, and caregivers who participate in ALZ-NET through their health care providers have access to support and resources through the Alzheimer’s Association, including additional opportunities to participate in research.

Visit ALZ-NET

A word from Maria C. Carrillo, Ph.D., Chief Science Officer and Medical Affairs Lead, Alzheimer's Association

"We are entering a new phase of Alzheimer's treatment. Data from real-world settings often provide unique insights into the way patients receive real-world care beyond what can typically be learned through clinical trials. In addition, ALZ-NET aspires to alleviate health inequity through an inclusive approach in a broad patient population treated in real-world settings."

Why should clinicians participate in
ALZ-NET?

Stay up to date on the latest developments in dementia research and care when you participate in ALZ-NET. The network provides value-driven solutions that address clinician time commitment and education, resources, and tools to enhance the clinician's knowledge, comfort, and ability to provide care.

Through participation in ALZ-NET, providers can:

Leverage the Alzheimer’s Association’s experience collaborating with a national network of providers.
Receive site remuneration for operations and data collection, including site start up and case-based data entry payments.
Utilize ALZ-NET as a pathway to Medicare coverage for anti-amyloid Alzheimer’s therapies that have received traditional FDA approval.
Gain insights on your patient population through data shared back to your institution.
Adopt new solutions to capturing, interpreting and harmonizing Alzheimer’s and other dementia data and insights that will inform quality improvement strategies.
Access resources that are aggregated through ALZ-NET to support clinicians and their staff in emerging science.
Receive educational support for the appropriate use of therapies, biomarker interpretation, and safety monitoring.

To learn more about participating in ALZ-NET, visit alz-net.org.

ALZ-NET International

ALZ-NET International connects ALZ-NET with Real-World Data (RWD) platforms globally, providing opportunities to share resources, exchange ideas and amplify impact. ALZ-NET International partners meet quarterly to share updates and initiatives, including at an annual in-person meeting at the Alzheimer’s Association International Conference (AAIC). Collaboration between ALZ-NET International partners is encouraged through the formation of working groups to explore areas of mutual interest.

International real-world data platforms and platforms in development are invited to apply for the Alzheimer's Association Funding Program for Global Real-World Data Platforms (ALZ-RWD), which aims to advance RWD by providing funds to develop, expand and align RWD platforms' infrastructure, data and impact globally.

Learn more about ALZ-NET International.